SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001521536-13-000951
Filing Date
2013-11-18
Accepted
2013-11-18 16:09:28
Documents
12
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 q1101300_10q-biozone.htm 10-Q 647013
2 q1101300_ex3-4.htm EX-3.4 544
3 q1101300_ex31-1.htm EX-31.1 10918
4 q1101300_ex31-2.htm EX-31.2 10871
5 q1101300_ex32-1.htm EX-32.1 10059
12 GRAPHIC ex3-4.jpg GRAPHIC 231963
  Complete submission text file 0001521536-13-000951.txt   4135596

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE bzne-20130930.xml EX-101.INS 365659
7 XBRL SCHEMA FILE bzne-20130930.xsd EX-101.SCH 47852
8 XBRL CALCULATION FILE bzne-20130930_cal.xml EX-101.CAL 49293
9 XBRL DEFINITION FILE bzne-20130930_def.xml EX-101.DEF 149173
10 XBRL LABEL FILE bzne-20130930_lab.xml EX-101.LAB 245801
11 XBRL PRESENTATION FILE bzne-20130930_pre.xml EX-101.PRE 238544
Mailing Address 550 SYLVAN AVENUE, SUITE 101 ENGLEWOOD CLIFFS NJ 07632
Business Address 550 SYLVAN AVENUE, SUITE 101 ENGLEWOOD CLIFFS NJ 07632 201-608-5101
BIOZONE PHARMACEUTICALS, INC. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 205978559 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-146182 | Film No.: 131227123
SIC: 2834 Pharmaceutical Preparations